121 related articles for article (PubMed ID: 34011485)
21. Normal patterns of 18F-FDG appendiceal uptake in children.
Reavey HE; Alazraki AL; Simoneaux SF
Pediatr Radiol; 2014 Apr; 44(4):398-402. PubMed ID: 24287869
[TBL] [Abstract][Full Text] [Related]
22. Does dual-time-point
Wu B; Zhao Y; Zhang Y; Tan H; Shi H
Hell J Nucl Med; 2017; 20(1):79-82. PubMed ID: 28315913
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W
Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314
[TBL] [Abstract][Full Text] [Related]
24. Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.
Blum KA; Young D; Broering S; Lucas MS; Fischer B; Lin TS; Grever MR; Byrd JC
J Clin Oncol; 2007 Dec; 25(35):5624-9. PubMed ID: 17984187
[TBL] [Abstract][Full Text] [Related]
25. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
[TBL] [Abstract][Full Text] [Related]
26. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.
Mayerhoefer ME; Jaeger U; Staber P; Raderer M; Wadsak W; Pfaff S; Kornauth C; Senn D; Weber M; Wester HJ; Skrabs C; Haug A
Invest Radiol; 2018 Jul; 53(7):403-408. PubMed ID: 29642081
[TBL] [Abstract][Full Text] [Related]
27. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome.
Alix L; Néel A; Cador B; Smail A; Serratrice J; Closs-Prophette F; Jego P; Devillers A; Decaux O
Autoimmunity; 2019; 52(7-8):264-271. PubMed ID: 31646899
[No Abstract] [Full Text] [Related]
29. Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.
Falchi L; Keating MJ; Marom EM; Truong MT; Schlette EJ; Sargent RL; Trinh L; Wang X; Smith SC; Jain N; Estrov Z; O'Brien S; Wierda WG; Lerner S; Ferrajoli A
Blood; 2014 May; 123(18):2783-90. PubMed ID: 24615780
[TBL] [Abstract][Full Text] [Related]
30. (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
Mylam KJ; Kostakoglu L; Hutchings M; Coleman M; Lamonica D; Czuczman MS; Diehl LF; Nielsen AL; Jensen P; Loft A; Hendel HW; Iyer V; Leppä S; Jyrkkiö S; Holte H; Eriksson M; Gillstrøm D; Hansen PB; Seppänen M; Hjorthaug K; Brown Pde N; Pedersen LM
Leuk Lymphoma; 2015 Jul; 56(7):2005-12. PubMed ID: 25330442
[TBL] [Abstract][Full Text] [Related]
31. Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
Tan D; Gill S; Loh N
Cancer Med; 2020 Oct; 9(20):7469-7476. PubMed ID: 32846054
[TBL] [Abstract][Full Text] [Related]
32. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
33. Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?
Iliaz R; Cavus B; Yegen G; Alcin G; Gulluoglu M; Karaca C; Demir K; Besısık F; Kaymakoglu S; Turkmen C; Akyuz F
Acta Gastroenterol Belg; 2018; 81(4):471-475. PubMed ID: 30645914
[TBL] [Abstract][Full Text] [Related]
34. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
Kurtipek E; Çayci M; Düzgün N; Esme H; Terzi Y; Bakdik S; Aygün MS; Unlü Y; Burnik C; Bekci TT
Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234
[TBL] [Abstract][Full Text] [Related]
35. Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma.
Zhou S; Chen W; Lin M; Chen G; Chen C; Huo C; Du X
J Int Med Res; 2021 Jul; 49(7):3000605211029809. PubMed ID: 34250823
[TBL] [Abstract][Full Text] [Related]
36. Sequential
Bomanji J; Sharma R; Mittal BR; Gambhir S; Qureshy A; Begum SMF; Paez D; Sathekge M; Vorster M; Sobic Saranovic D; Pusuwan P; Mann V; Vinjamuri S; Zumla A; Pascual TNB
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3118-3129. PubMed ID: 32483653
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract][Full Text] [Related]
38. F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.
Benjamin J; Hephzibah J; Shanthly N; Oommen R; Mathew D; Pavamani S; Rajnikanth J
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1333. PubMed ID: 33660434
[TBL] [Abstract][Full Text] [Related]
39. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
